SP-650003

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSP-650003
Drug Alias NameSP-650003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammationInflammatory Bowel DiseasesOsteoarthritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignal Research Division
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignal Research DivisionSibia Neurosciences Inc
Active IndicationsN/A
Inactive IndicationsInflammationInflammatory Bowel DiseasesOsteoarthritis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A